Table Of Content

INDEX TO POSTGRADUATE VOLUME 99 MEDICINE JANUARY-JUNE 1996 SUBJECTS ABDOMEN ANEMIA ension, costs of treatment DELIVERY OF HEALTHCARE ¢ Abdominal infections, diagnos- e Iron deficiency anemia. (PN) ond long-term consequences of © Market forces shaping today’s tic imaging. $9(3):176 99(3):288 cost containment. 99(4):241* medical practice. (ED)9 9(6):15 ACCIDENTS ¢ Hypertensive crises, necessity * Putting in control of ¢ Accidental hypothermia, effects ANTIBODIES for prompt recognition and man- — — 21 ‘ of heat loss on body systems, ¢ Antiphospholipid syndrome, agement. 99(1):189* ° ent care clinic, efficiency treatment. 99(1):77* overview of detection and man- ¢ Ischemic coronary artery dis- and Ghectveneee. 99(4):161" ¢ Falls caused by peripheral neu- agement. 99(6):105* ease, usefulness of percutaneous DEPRESSION ropathy in the elderly, detection APPETITE DISORDERS revascularization strategies. 99(2): ¢ Dysthymic disorder, diagnostic and treatment. 99(6):161* e Anorexia. (PN) 99(6):278 125° characteristics, management. ACQUIRED IMMUNODEFICIENCY e Anorexia nervosa and bulimia ¢ Iséhemic heart disease, choos- SYNDROME: See AIDS nervosa, behavioral clues, role of 2a diagnostic tests. ¢ Management, detection and ADOPTION primary care physicians in inter- treatment, current trends in pri- ¢ International, screening for in- vention. 99(1):161* © Myocardial infarction, risk strat- mary care. 99(5):179* fectious diseases and develop- ARTHRITIS: See Rheumatic dis- ification in survivors. 99(4):207* DERMATITIS mental delay. 99(4):70* eases ¢ Thrombosis in patients with an- ¢ Pruritus, overview of current AGING eo syndrome. 99(6): therapeutic strategies. . 99(1):173* e Acute respiratory failure, role of BIOPSY 1 noninvasive positive pressure ¢ Fine-needle aspiration, pulmo- CATHETERIZATION * Complications, strategies for ventilation in treatment. 99(6):221 nary nodule. 99(2):248 * Cardiac, for risk stratification in detection and treatment. 2895147 ¢ Brain failure, careful evaluation BLEEDING: See Hemorrhage survivors of acute myocardial in- * Gestational, risk factors,d i- to reveal potentially reversible BLOOD farction. 99(4):212 nosis and managemen9t9.(3 ):1 causes. 99(5):125* e Exchange transfusion for neo- CHEMOTHERAPY: Drugs, an- ¢ Insulin pump therapy, accep’ ° ———— ase information. natal jaundice. 99(3):193 tineoplastic able — to injectio1n (PN) 99(4):282 BODY WEIGHT CHILD DEVELOPMENT DISORDERS apy. 99(3):125 ¢ Functional assessment in older —- in anorexia. (PN) 99/6): * Developmental assessment of © Ket joacidosis and hyperosmo- patients, overview, improving qual- the internationally adopted child, lar nonketotic state, evaluation ity of life. 99(5):101* ¢ Obsession in eating disorders, screening for delays. 99(4):81 . 99(6):143* ¢ Influenza in eiderly, difficulties behavioral clues, role of primary CHOLESTEROL ¢ Type Ii, new and traditional in diagnosis, strategies for pre- care physicians in intervention. e Reduction in coronary artery treatment options. 99(3):109* vention. 99(2):138* 99(1):161* disease. 99(2):89 DIAGNOSTIC TECHNIQUES © Mobility and balance in elderly, BRAIN CLINICS, CARE © Bronchoalveolar lavage in diag- guide to assessment. 99(3):269* e Effect of drug therapy for Parkin- © Providing efficient, cost-effective nosis of nosocomial pneumonia. * Necrotizing otitis externa, man- son’s disease. 99(1):52 care. 99(4):161* 99(3):227 agement. 99(5):157 ¢ Failure in older patients, evalu- COLONIC See Gastro- © For clinical ci nosis of com- e Parkinson's disease, treatment ation. 99(5):125* intestinal diseases munity-acquire pneumonia. strategies. 99(1):52* BRONCHITIS COMPUTERS 95 ¢ Peripheral neuropathy, cause ° omen patient information. (PN) ¢ CD-ROM drives in medical prac- ¢ For interstitial cystitis. 99(5):202 of falls, detection and treatment. 99(1):21 tice. (DD) 99(2):35 ¢ imaging studies in evaluation of 99(6):161* ° el acute ~" jaca ¢ E-mail, cverview, uses for coronary artery disease. 99(2):65 e Physiologic changes, pharma- management. 99(4):89 i 51 ¢ Imaging techniques in evalua- cologic implications. weno 111° tion of various infectious dis- ¢ Risk factor for nosocomial pneu- CANCER: See Neoplasms up.“ O082 303 1 eases. 99(3):175* monia. 99(3):222 CARDIOVASCULAR ical practice, distinguish- © In differentiation of benign and e Urinary inc’ ‘tinence, basic e Anticoagulant therapy, oral, a.n e from expensive malignant pulmonary nodules. types and mana, nent. 99(5):137* practical aspects. 99(6):81* extras. (DD) 99(5):29 99(2):246 * Coronary artery disease, phar- © Modems, ing and them ¢ Prostate-specific antigen test- -° , in HIV-infected patients, macologic prevention, clinical tri- for your medical practice. (DD) ing for prostate cancer, practical assessment. 99(3):78* als. 99(2):109* 99(4):47 ry toef vaelues . 99(2):227° ¢ Opportunistic funga! infections ¢ Coronary artery disease, rec- ¢ Practical applications to medi- in diagno- in patients. with HIV disease, di- ommendations for lifestyle modi- cal practice. (DD) 99(1):39 sis of bomen yp neumonia. agnosis and treatment. 99(6):209* fications. 99(2):89* COST-BENEFIT ANALYSIS 99(3): 226 a e Deep venous thrombosis in © Costs of hypertension treatment, DISEee TNut:riti on pregnancy, use of low-dosage long-term realities of cost contain- DRUG INTERACTIONS *Major clinical discussion urokinase. (CR) 99(5):269 ment. 99(4):241* e With oral anticoagulant ther- CV, Clinical Viewpoint ¢ Exercise stress testing. (PN) apy. 99(6):89 CR, Case Report 99(2):276 DEATH/DYING DRUG THERAPY DD, Digital Doc ¢ Heparin therapy, indications for, * Combining the art and science © Chelation therapy for lead poi- ED, Editorial principles of monitoring. 99(6):64* of medicine to relieve suffering, soning. 99(3):211 PH, Physician-at Large © Hypercholesterolemia, role of useful suggestions. 99(6):189* ¢ Effects of related physio- PN, Patient Notes dietary fiber in cholesterol reduc- logic changes. 5):114 tion. 99(2):168 VOL 99/NO 6/JUNE 1996/POSTGRADUATE MEDICINE INDEX TO VOLUME 99 CONTINUED ¢ For acute — depressive DRUGS, * Glaucoma, guide to recognition HEALTH POLICY states. (CR) 99(4):146 © Aspirin for primary prevention of and management. 99(5):247* * Opportunity for physicians to © For term con- coronary artery disease. 99(2):118 * Iritis, recognition and manage- ooer2tc ontro! of healthcare. (ED) — of cost containment. DRUGS, SIDE EFFECTS ment. 99(2):255* 99¢8):241 * Hepatotoxic effects of tubercu- ¢ Recognizing common condi- HEART DISEASE: See Cardiovas- ¢ For moderate Parkinson's dis- losis therapy. 99(5):217* tions in which ophthal ic re- cular diseases ease. 99(1):52* © Of common glaucoma medica- ferral is . 99(4):107" HEART RATE © Specific agents for management tions. 99(5):257 © Retinopathy, diabetic, detec- ¢ Normal sinus rhythm, standards of hypertensive crises. 99(1):191 DRUGS, THROMBOLYTIC tion and treatment. 99(3):147 too high. (CV) 99(2):263 onEee, ANTIBIOTIC * Low-dosage urokinase for deep HEMATOLOGIC ins for treatment of venous thrombosis in pregnancy. FEVER * Anemia, iron deficiency. (PN) streptococcal os 99(2): (CR) 99(5):269 ¢ In HIV-infected , aSSess- 99(3):288 ment. 99(3):78* ¢ Thrombocytopenia in antiphos- EAR DISEASES FIBER pholipid syndrome, overview of * Otitis externa, management. * Dietary, role in prevention and — and management. 99(6): 99(5):153* treatment of disease. 99(2):153* e For urinary tract infection in EATING DISORDER: See Appetite FUNGAL DISEASES HEMORRHAGE women. 99(4):192 disorders © Opportunistic infections in HIV- ¢ Acute —-. evaluation and © Selecting cost-effective regi- EDUCATION, MEDICAL infected patients, diagnosis and treatment. 99(5):83 men for community-acquired ¢ Future oversupply of physi- treatment. 99(6):209* © Bleeding risk during oral anti- pneumonia. 99(1):109* — role of international medi- coagulant therapy, assessment. * Vancomycin-resistant entero- graduates, recommendations. GASTROINTESTINAL DISEASES 6:83 cocci, key features, guidelines for Pan9 9(5):15 © Colorectal cancer, benefits of an AMhd a anticoagu- drug therapy. 99(5):60° ELDERLY: See Aging dietary fiber. 99(2):156 lantt herapy. 99( DRUGS, MEDICINE © Colorectal cancer, screening, ¢ In Ebola virus , 99(5):75 © For patients with antiphospho- * Hypertensive crises, necessity present strategies, future pros- HEMORRHOIDS lipid antibodies who have throm- for prompt recognition and man- pects. 99(3):253° © Patient information. (PN) 99(5): bosis. 99(6):120 agement. 99(1):189* * Diverticulitis, role of dietary fiber 280 ¢ Heparin therapy, current regi- ENDOCRINE DISORDERS in rraamaas and treatment. 99(2): ae mens,— - of monitoring. * Diabetes: See Diabetes 1 ¢ Therapy, indications for, princi- 99(6):64 * Hyperprolactinemia, causes, ¢ Gastroesophageal reflux, rec- ples of monitoring. 99(6):64* © Heparin Me new develop- evaluation, and treatment. 99(5): ognizing atypical presentations, e Therapy, new developments. ments. 99(6):129 treatment. 99(4):231* 99(6):129°* ¢ Oral therapy, practical aspects. ENVIRONMENTAL HAZARDS ¢ Inflammatory bowel disease, HOSPITALS, COMMUNITY 99(6):81* * Lead poisoning, screening, benefits of dietary fiber. 99(2):167 ¢ Nosocomial enterococcal dis- DRUGS, ANTIDEPRESSANT treatment strategies. 99(3):201* Irritable bowel syndrome, ben- easo, resistant strains, increasing e For treatment of depression. EQUIPMENT ots of dietary fiber. 99(2):154 prevalence. 99(5):60 5):185 ¢ For team physicians on side- Hae sage and feeding tubes, HYPERGLYCEMIA ‘or treatment of dysthymic dis- lines. 99(5):237 importanceo f proper placement. * Decompensated hypergly- order. 99(6):237 © Insulin pump therapy. 99(3):125* 99(5):165* cemic states in adults, diagnosis DRUGS, ANTIFUNGAL ESTROGEN © Proctalgia fugax, guide to recog- and management. 99(6):143°* e For cryptococcal! disease in © Effect on cardiovascular system. = therapeutic strategies. 99(4): HYPERTENSION: See Cardiovas- HIV-infected patients. 99(6):211 99(2):115 cular diseases ¢ For histoplasmosis in HIV- ETHICS, ¢ Vancomycin-resistant entero- HYPOTHERMIA infected patients. 99(6):218 © Issues involved in -— donation cocci, key features,— _— for ¢ Accidental, effects of heat loss DRUGS, ANTIHISTAMINE and transplantation. (ED) 99(3):15 drug therapy. 99(5): — body systems, treatment. 99(1): © Oral, for pruritus. 99(1):176 GENITAL DISEASES DRUGS, ANTILIPIDEMIC © To reduce risk of coronary artery ¢ Urinary tract infection, current ¢ in preventing atherosclerosis, disease. 99(2):102 recommendations for diagnosis IMMUNIZATION Clinical trials. 99(2):109 EXERCISE TESTING and treatment. 99(4):189* © For influenza in elderly, recent * In evaluation of ischemic heart * Vaginal prolapse, nonsurgical information. 99(2):143 ¢ Tuberculosis chemotherapy, disease. 99(2):64 management techniques. 99(4): INCONTINENCE hepatotoxic effects. 99(5):217* — information. (PN) 99(2): . ne in older patients, basic DRUGS, ANTIVIRAL types and management. 99(5):137* ¢ For treatment of influenza in el- EVE DISORDERS. derly. 99(2):144 © Cataracts. (PN) 99(4):282 * Guide to recognition and man- ¢ For older patients, overview of DRUGS, CORTICOSTEROID * Common conditions to treat in agement. 99(5):247* functional assessment to improve © Topical, for pruritus. 99(1):179 primary care office, ways to avoid GYNECOLOGY: See Obstetrics/ quality of life. 99(5):101* DRUGS, HYPOGLYCEMIC potentially serious consequences. Gynecology © Mobility and balance in elderly, * Oral, in pharmacologic treat- 99(4):119 guide to assessment. 99(3):269* ment of type Ii diabetes. 99(3):115 continued VOL 99/NO 6/JUNE 1996/POSTGRADUATE MEDICINE INDEX TO VOLUME 99 CONTINUED INFANTS e Vancomycin-resistant entero- LIVER DISEASES NEOPLASMS * Complications from gestational cocci, key features, guidelines for © Hepatotoxic effects of tubercu- * Colorectal cancer, benefits of diabetes. 99(3):166 drug therapy. 99(5):60* losis therapy. 99(5):217* dietary fiber. 99(2):156 ¢ Eye infection, chronic, diagno- INFLAMMATION e Jaundice, neonatal, guide to * Colorectal cancer screening, baera nd treatment. 99(4):119 ¢ Bronchitis, acute. (PN) 99(1): differential diagnosis and man- present strategies, future pros- © Neonatal jaundice, guide to dif- 214 agement. 99(3):187* ferential diagnosis and manage- ¢ Bronchitis, chronic, acute ex- ulU NG DISEASES * Oral lesions, cancerous, warn- ment. 99(3):187* acerbations, management. 99(4): * Chest infections, diagnostic ing signs, diagnn osis, and treat- INFECTION imaging. 99(3):175 ment choices. ¢ Abdominal, diagnostic imaging. ® Iritis, a and manage- ¢ Pulmonary nodule, differential ¢ Prostate cancer, prostate-spe- 99(3):176 ment. 99(2):2' — and management. 99(2): cific antigen testing, practical in- -— diagnostic imaging. 99(3): INFLUENZA t ion of vane. 99(2):227* 1 ¢ In elderly, difficulties in diagno- * Roentgenographic lung abnor- . itary pulmonary nodule, dif- * Clostridial myonecrosis (gas sis, strategies for preverition. 99(2): malities, distinguishing from ferential diagnosis and manage- gangrene) after traumatic injury, 138* pneumonia, role of history taking ment. 99(2):246* guide to early recognition and INSULIN and examination in accurate di- NEUROLOGIC MANIFESTATIONS treatment. 99(4):217* ¢ Intravenous therapy for diabetic agnosis. 99(1):139* © Brain failure in older patients, * Community-acquired pneumo- ketoacidosis. 99(6):146 careful evaluation to reveal poten- nia, accurate diagnosis. 99(1):95* ¢ Pump therapy, acceptable al- MEDICAL tially reversible causes. 99(5):125* * Community-acquired pneumo- ternative to injection therapy for e Adding versatility to computers © Diabetic a, detection nia, cost-effective antimicrobial diabetes. 99(3):125* with CD-ROM drives. (DD) 99(2): and treatment. 99(3):155 therapy. 99(1):109* © Role in therapy for h perosmo- ¢ Parkinson's disease, strategies ¢ Ebola virus disease, manifesta- lar nonketotic state. 6):150 * Computers with modems, us- maximizing treatment. 99(1):52* tions, management and preven- HEALTH ing them to enhance your prac- ¢ Peripheral neuropathy, cause tive measures. 99(5):75* ¢ Financial commitment by insur- tice. (DD) 99(4):47 of falis in elderly, detection and © Fever in HIV-infected patients, ers to long-term goais of therapy ¢ Impact of market forces. (ED) treatment. 99(6):161* assessment. 99(3):78* for hypertension, effects of cost 99(6):15 NURSING HOMES ¢ Fungal, opportunistic, in HIV- containment. 99(4):241* ¢ Incorporating computers into ¢ Management of influenza out- infected go diagnosis and INTUBATION everyday practice. (DD) 99(1):3S breaks. 99(2):147 treatment. 99/6 ):209 ¢ Nasogastric and feeding tubes, e Using computers, distinguish- py ty * Influenza in elderly, difficulties proper placement. 99(5):165* ing requirements from expensive pwn e|f iber, role in prevention in diagnosis, strategies for pre- IRON extras. (DD) 99(5): of disease. 99(2):153* vention. 99(2):138* © Deficiency, cause of anemia. ¢ Using E-mail effectively. (DD) a. y ome modifications to reduce ¢ Joint space, infectious arthritis, (PN) 99(3):288 99(3):51 risk factors in coronary artery dis- re and treatment. 99(4):127* METI DISORDERS ease. 99(2):89 » Musculoskeletal, diagnostic JAUNDICE ¢ Diabetic ketoacidosis and hy- ¢ Eating disorders, behavioral imaging. 99(3):178 * Neonatal, guide to differential nonketotic state, eval- clues, guide to intervention. 99(1): * Nosocomial pneumonia, diag- diagnosis and management. uation and . 99(6):143* 161* nosis and treatment. 99(3):221* 99(3):187* * Hyperprolactinemia, causes, ¢ tron deficiency anemia. (PN) © Otitis externa, management. evaluation, and treatment. 99(5): 99(3):2 88 99(5):153* KIDNEY DISEASES ¢ Nasogastric and feeding tubes, * Pneumonia, nonzoonotic atypi- * Diabetic nephropathy, detec- MOUTH DISEASES importance of placement. cal, diagnosis and treatment. tion and treatment. 99(3):150 ¢ Cancerous oral lesions, warn- oo) 165* 99(1): 123°; (correction) 99(4):64 ing signs, diagnosis and treat- ¢ Pneumonia, risk factors for and LABORATORY INVESTIGATION ment choices. 99(4):149* OBESITY causes of delayed resolution, © Monitoring effect of oral antico- MUSCUL' © Benefits of dietary fiber in weight workup strategy. 99(1):151* agulant therapy. 99(6):81* * Assessi loss. 99(2):168 * Screening the internationally ¢ Monitoring heparin therapy. in OBSTETRICS/GYNECOLOGY adopted child. 99(4):70 99(6):70 ¢ Infections, diagnostic imaging. ¢ Gestational diabetes, risk fac- © Streptococcal pharyngitis, re- ¢ Prostate-specific antigen test- 99(3):178 tors, di and management. current, treatment options. ing for prostate cancer, practical ¢ Leg cramps, nocturnal, contro- 99(3):165* 99(2):211*; (Correction) 99(5):46 interpretation of values. 99(2):227* versy over use of quinine, treat- * Pregnancy and deep venous ¢ Tinea versicolor, Ciagnosis and ¢ Testing for antiphospholipid ment and prevention. 99(2):177* thrombosis, use of low-dosage treatment. 99(6):179 syndrome. 99(6):115 MYOCARDIAL INFARCTION: See urokinase. (CR) 99(5):269 e Upper respiratory tract, cause LEAD Cardiovascular diseases ¢ Urinary tract infection, current of exacerbations of chronic bron- ¢ Poisoning, screening, treatment treatment approaches. 99(4):192 chitis, it. 99(4):95 strategies. 99(3):201* NASAL DISORDERS ¢ Vaginal prolapse, nonsurgical ¢ Urinary tract, current recom- LEG e Acute yor evaluation and management techniques. 99(4): for diagnosis and treat- ¢ Cramps, nocturnal, controversy treatment. 99(5):83 ment. 99(4):189* over use of quinine, treatment continued and prevention. 99(2):177* VOL 99/NO 6/JUNE 1996/POSTGRADUATE MEDICINE 6 INDEX TO VOLUME 99 CONTINUED OCULAR DISORDERS: See Eye PHARYNGEAL DISEASES ¢ Influenza vaccine, recent infor- RECTAL DISEASES disorders ¢ Streptococcal pharyngitis, re- mation. 99(2):143 * Hemorrhoids. (PN) 99(5):280 OTORHINOLARYNGOLOGIC current, treatment options. ¢ Measures to prevent infection ¢ Proctalgia fugax, guide to rec- DISEASES 99(2):211*; (correction) 99(5):46 —- after splenectomy. 99(6): nition, therapeutic strategies. ¢ Acute —_, evaluation and PHYSICAL EXAMINATION 99(4):263° treatment. 99(5):83 e Functional assessment in older ¢ Prevention of type Il diabetes, RENAL DISEASeSe KEidnSey: di s- ¢ Head and neck manifestations patients, overview. 99(5):101* Clinical trials. 99(3):109 eases of gastroesophageal reflux. 99(4): PHYSICIAN-PATIENT RELATIONS ¢ Preventive measures in chronic RESPIRATORY DISEASES 233 * Coping with personal pain bronchitis. 99(4):101 © Acute respiratory failure, role of ¢ Oral cancer, warning signs, di- within family practice. (ED) 99(1):15 © Role of dietary fiber in preven- noninvasive positive pressure agnosis, and treatment choices. ¢ Patients’ views of physicians. tion and treatment of disease. 99(2): ventilation in treatment. 99(6):221* 99(4):149* (ED) 99(4):21 153° © Bronchitis, acute. (PN) 99(1):214 ¢ Otitis externa, management, PROSTATIC * Bronchitis, chronic, acute ex- when to refer. 99(5):153* © Combining the art and science * Prostatic-specific antigen test- - ions, management. 99(4): XYGEN of medicine to relieve suffering, ing for prostate cancer, practical e Hyperbaric, therapy, for gas useful suggestions. 99(6):189* interpretation of values. 99(2):227* ¢ Chronic pulmonary disorders, gangrene. 99(4):219 © Healing the healer, coping with PSYCHIATRIC/PSYCHOSOCIAL association = astroesoph- personal pain within family prac- DISORDERS ageal reflux. 99( PAIN tice. (ED) 99(1):15 * Anorexia. (PN) 99(6):278 ¢ Pneumonia. . cae diagnosis * Chest, atypical presentation of ¢ Making better use of computer © Depression, detection and treat- and treatment. 99(1):123*; (cor- gastroesophageal reflux. 99(4): technology in everyday practice. ment, current trends in primary rection) 99(4):64 31 (DD) 99(1):39 care. 99(5):179* ¢ Pneumonia, community- ¢ Rectal, proctaigia fugax, guide e Need to understand market ¢ Dysthymic disorder, diagnostic acquired, accurate diagnosis. to recognition, therapeutic strate- forces shaping today’s medical 99(1):95* gies. 99(4):263* practice. (ED) 99(6):15 ¢ Pneumonia, community- © Suffering, relief of, suggestions © Opportunity to ~ os control of ¢ Eating disorders, behavioral acquired, cost-+ stctove antimi- for combining the art and science healthcare. (ED) 99(2):2 clues, role of pri care physi- 1):109 of medicine. 99(6):189* © Oversupply in near Taal role cians in intervention. 99(1):161* ¢ Pneumonia, risk factors for and PATIENT EDUCATION of international medical graduates, * Mania, case with insomnia as causes of delayed resolution, * Acute bronchitis. (PN) 99(1):214 recommendations. (ED) 99(5):15 presenting symptom. (CR) 99(4):143 ¢ Anorexia. (PN) 99(6):278 e Patients’ perceptions. (ED) PUBLIC HEALTH > Pulmonary * Cataracts. (PN) 99(4):282 99(4):21 * Nosocomial pneumonia, diag- tious, radiographic presentations ¢ Diabetes education, therapeu- e Primary care, role in raising nosis and treatment. 99(3):221 mimic pneumonia, role of history tic component. 99(3):111 awareness of need for organ do- e Vancomycin-resistant entero- taking and examination in accu- e Exercise stress testing. (PN) nation. (ED) 99(3):15 cocci, key features, guidelines for rate diagnosis. 99(1):139* 99(2):276 e Sports event and team, appro- drug therapy and for limiting con- RHEUMATIC ¢ Hemorrhoids. (PN) 99(5):280 priate preparation key to success. tact and spread. 99(5):60° ¢ Infectious arthritis, need for ¢ lron deficiency anemia. (PN) ): 3 * PULMONARY DISEASES: See Lung prompt diagnosis and treatment. 99(3):288 diseases; Respiratory diseases 99(4):127* e Lifestyle modification in coro- e Atypical, diagnosis and treat- ¢ Rheumatoid arthritis, perioper- nary artery disease. 99(2):89* ment. 99(1):123*; (correction) OF HEALTHCARE sve management. 99(2):191* PEDIATRICS '4):64 ¢ Effect of market forces, pur- ¢ Anorexia. (PN) 99(6):278 © Community-acquired, accurate chaser definitions of quality. (ED) SCREENING * Chronic eye infection in infants, diagnosis. 99(1):95* 99(6):15 ¢ For colorectal cancer, present diagnosis and treatment. 99(4):119* ¢ Community-acquired, cost- QUININE ~~ future prospects. 99(3): ating disorders, behavioral effective antimicrobial therapy. ¢ Over-the-counter preparations clues, role of primary care physi- 99(1):109* banned for treatment and preven- ¢ For infectious diseases and de- cians in intervention. 99(1):161* ¢ Delayed resolution, risk factors tion of nocturnal leg cramps. 99(2): velopmental in the interna- ¢ International adoptions, screen- for and causes, workup strategy. 177" tionally adopted child. 99(4):70* ing for infectious diseases and 99(1):151* © For lead toxicity. 99(3):201 developmental delay. 99(4):70* * Nosocomial, diagnosis and treat- RADIOGRAPHY SKIN DISEASES ¢ Lead poisoning, screening for ment. 99(3):221* ¢ Proper positioning of nasogas- e Necrosis and purple toes syn- toxicity, treatment strategies. POISONING tric and feeding tubes. 99(5):165* drome, = of warfarin 99(3):201 © Lead, screening for toxicity, treat- RADIOLOGIC DIAGNOSIS ; ):92 © Neonatal jaundice, guide to dif- ment strategies. 99(3):201* ¢ Imaging techniques in evalua- ¢ Nongenital warts, treatment ferential diagnosis and treatment. PREGNANCY See Obstetrics/Gy- tion of various infectious diseases. i '3):245* 99(3):187* necology 99(3):175* ¢ Pigmentation disorders, char- ¢ Streptococcal pharyngitis, re- PREVENTIVE MEDICINE acteristics and treatment. 99(6): current, treatment options. 99(2): ¢ Bronchiti=, chronic, acute exac- ¢ For treatment of stage T1 and 177* 211*; (correction) 99(5):46 erbations, management. 99/4):89"* T2 oral cancer. 99(4):152 continued VOL 99/NO 6/JUNE 1996/POSTGRADUATE MEDICINE UPRES RRR T A INDEX TO VOLUME 99 CONTINUED ¢ Pruritus, overview of current e Organ A rt na ethical ¢ Laser therapy for nongenital * Prostate-specific antigen test- therapeutic strategies. 99(1):173* issues. (ED ) 99(3):15 warts. 99(3):248 SLEEP DISORDERS * Pelvic ive, for vagi- * Noninvasive positive pressure ¢ Insomnia as ting symp- vuhgueienan, 99(4):184 ventilation, role in treating acute ¢ Urinary incontinence in older toof mmani a. (CR) 99(4):143 ¢ Perioperative -— of patients, basic — and man- SMOKING rheumatoid arthritis, areas of con- e° hens rewvaesceultari zation agement. pan 37* ¢ Cessation to prevent chronic 902)— care physicians. strategies for ischemic coronary bronchitis. 99(4):101 artery disease. 99(2):125* rah neen eon e014)1 74 * Risk factor in coronary artery ° utions for patients on an- e Phototherapy for neonatal rinary tract infection, current ti ulation therapy. 99(6):89 jaundice. 99(3):193 secemunendations for diagnosis * Vaginal pessaries for genital and treatment. 99(4):189* * ene risk of infection. 99(6): prolapse. (4):175 SPORTS MEDIC!NE TRANSPLANTATION VACCINATION: See immunization ¢ Event and team physicians, ap- * Ethical issues. (ED) 99(3):15 propriate preparation key to suc- TERMINAL CARE cess. 99(5):237* * Combining the art and science of * Accidentalh , effects SURGERY poser to relieve suffering. of heat loss on body systems, ¢ Arterial ligation and other surgi- treatment. 99(1):77°* tions, management and preven- cal interventions for acute epis- THERAPEUTICS * Followed by gas gangrene, guide tive measures. 99(5):75* ° eg a Aa ge hye to early nition and treatment. © Influenza in elderly, difficulties ery for re- medicine to , useful 99(4):217° in diagnosis, strategies for pre- vascularization in patients with may pon TUBERCULOSIS vention. 99(2):138* “—. 99(2): — * Hepatotoxic effects of therapy. ¢ Nongenital warts, treatment ° i it, for gas 99(3).2 47 99(5):217* options. 99(3):245* — Sod: 219 ¢ For 2. anterior and pos- Tumors: See Neopiasms © Electrodesiccation of nongeni- tortor. 99(5):88 WARTS tal warts. 99(3):248 © Hyperbaric oe therapy to UROLOGIC DISEASES ¢ Nongenital, treatment options. * Oncologic, for oral cancer. 99(4): reduce morbiditayn d mortality in * Interstitial cystitis, diagnosis 99(3):245* 152 cases of gas gangrene. 99(4):219 and treatment. 99(5):201* See Trauma AUTHORS ABOUSSOUAN LS ANDERSON EG BARR LL Acute exacerbations of chronic —— as patients. (PH) 99(4): Gastroesophageal! reflux: Rec- bronchitis: Focusing manage- nizing atypical presentations. ment for optimum results. 99(4):89 ae smokers quit. (PH) 99(5): 99(4).231 ALI J BASS JB Jr Hepatotoxic effects of tubercu- The kindest cut. (PH) 99(2):29 See Broughton WA losis therapy: A practical ap- Last words. (PH) 99(3):37 BAUM N proach to a tricky management Two by two. (PH) 99(1):25 See Mobley DF; Randrup E problem. 99(5):217 ASHTON-MILLER JA BENNETT WG ALVIA See Richardson JK Benefits of dietary fiber: Myth or Acute epistaxis: How to spot the medicine? 99(2):153 tical aspects of management. source and stop the flow. 99(5):88 BABB RR BERRY BR 99(6):81 Oral cancer: How to recognize Proctalgia fugax: Would you rec- Heparin therapy: Current regi- See also DevineD V the danger signs. 99(4):149 ognize it? 99(4):263 mens and principles of monitor- contionn puagee d26 4 ing. 99(6):64 VOL 99/NO 6/JUNE 1996/POSTGRADUATE MEDICINE INDEX TO VOLUME 99 CONTINUED BROUGHTON WA DAVILAG W HACKER SM LASKER MR ial pneumonia: Trying be poe prolapse: Management Common disorders of pigmen- Neonatal jaundice: When to to make sense of the literature. w—it h nonsurgical techniques. 99(4): tation: When are more than cos- treat, when to watch and wait. 99(3):221 —_ cover-ups required? 99(6): 99(3):187 BROWN SJ DEVINED V Should your son or daughter ge The yo mea mgs ap syn- HAGMAN HM Use of — in to medical school? (PH) 99(6):27 drome: When does the presence t entero- Two success stories. (CH) 99(5): of antiphospholipid antibodies re- cocci: The ‘superbug’ scourge CABREROS LJ quire therapy? 99(6):105 that’s coming your way. 99(5):60 LAVIE CJ Radiographic mimics of pne' DHOLAKIA S$ HARRIS ws introduction to symposium on monia: Pulmonary disorders to The solitary pulmonary nodule: See O’Keefe JH Jr ischemic heart disease. 99(2):60 in differential diagnosis. Is it malignant or benign? 99(2):246 HIRSCH IB Stable ischemic heart disease: 99(1):139 DRIMOUSSIS A Surveillance for complications Using stress and imaging proce- CARTER cu See Cabreros LJ of diabetes: Don’t wait for symp- dures to direct therapy. 99(2):63 New developments in acute an- toms before intervening. 99(3):147 See also Milani RV ticoagulation therapy: What im- ELLIOTT WJ HOLZMAN IR LECLERC KM provements over traditional hep- The costs of treating hyperten- See LaskerM R Benign nocturnal leg cramps: arin are on the horizon? 99(6):129 sion: What are the long-term real- HOSTETTERMK Current controversies over use of CASSIERE H ities of cost containment and Medical examination of the in- quinine. 99(2):177 resolution of pneumo- peel 99(4):241 ternationally adopted child: LEE-CHIONG TL Jr nia: When is slow healing too Screening for infectious diseases Accidental hypothermia: When show? 99(1):151 pyLayssry KS and delay. 99(4):70 thermoregulation is overwhelmed. CéFALU WT 99(1):77 Treatment of type I! diabetes: FEIN AM Through the) l ooking : H How LEONARDJ C What options have been added to See Cassiere H do patievnietw sus ? D) 99(4):21 Ready, set, go! Sports eo traditional methods? 99(3):109 FERNANDEZM P HUNTERJ C ona nda ft hee ld 99(5):23 CERDA JJ See MarcusA O See Stern EJ See Bennett WG FIGUEREDO VM See SStte m EJ CHAUDHRY | Risk stratification after acute JAFRIA LYSSY KJ glaucoma: A guide myocardial infarction: Which See PaisStS Il Perioperative management of for the primary care physician. studies are best? 99(4):207 JOHNSON DB rheumatoid arthritis: Areas of 99(5):247 FILE TM Jr See Hostetter MK concern for primary care physi- COULTER CH Community-acquired pneumo- JOYNER-TRIPLETT N cians. 99(2):191 The shifting healthcare market- nia: What’s needed for accurate See Alvi A place: Purchasers, not MCO’s, diagnosis. 99(1):95 MacKNIGHT C = the powers that be. (ED) 99(6): FONER BJ KAYE TB and balance in the el- 1 See Broughton WA Causes, con- derly: A guide to bedside assess- CUNHA BA FROMM RE Jr sequences, and treatment op- ment. 99(3):269 Atypical pneumonia: Extrapul- See Varon J tions. 99(5):265 MARCUS AO monary clues guide the way to di- KIRCHNER JT Insulin pump therapy: Accept- Maree 99(1):123; (correction) GARRATTK N Opportunistic | infections able alternative to injection ther- Percutaneous revascularization in patients with HIV disease: apy. 99(3):125 Community-acquired pneumo- strategies: Usefulness in isch- Combating cryptococcosis and nia: Cost-effective antimicrobial emic coronary artery disease. — 99(6):209 oe canceer e therapy. 99(1):109 99(2):125 ae future pros- introduction to symposium on GHARIBA M a a presenting symp- ppeecet s.S 8 8)2 pneumonia. 99(1):91 and feeding tubes: tom of mania. (CR) 99(4):143 JP The importance of proper place- KUZEL R See PPaaisi7t 3S Ul Noninvasive positive pressure ment. 99(5):165 Management of depression: MILANI RV ventilation: What is its role in GIUDICE JC Current trends in primary care. Pharmacologic prevention of ——? acute respiratory failure? See Curreri JP 99(5):179 coronary artery disease: What (6)221 GLECKMAN R do clinical trials show? 99(2):109 Assessment of fever in HiV- LANDOW K See also Lavie CJ See Gleckman R infected patients. 99(3):78 Nongenital warts: When is treat- MILLIKAN LE ment warranted? 99(3):245 Treating pruritus: What's new in DAVIDSON JA Diabetic ketoacidosis and LANDRY FJ safe relief of symptoms? 99(1):173 Gestational diabetes: Ensuring a olar nonketotic state: See Leclerc KM MIFIZA N successful outcome. 99(3):165 Gaining control over extreme LARSEN RR Otitis externa: Management in nye ic complications. 99(6): Healthca: the primary care office. 99(5):153 it? (ED) 99(2):21 continued VOL 99/NO 6/JUNE 1996/POSTGRADUATE MEDICINE INDEX TO VOLUME 99 CONTINUED MOBL7ZY DF Hemorrhoids. (PN) 99(5):280 Common eye disorders: Six pa- interstitial ; When urgency tape ea aeo f( DD) 99( Iron deficiency anemia. (PN) tie:nt s to treat, pitfalls to avoid. 99(4): and frequency mean more than Your ‘window’ to (oor 99(3):288 11 routine inflammation. 99(5):201 jormetion. (00)2 81-38 Two base- Introduction to symposium on MOLINA E ball greats challenge us to give eye disorders. 99(4):105 See La Vaileur J RAJENDRAN R the gift of life. (ED) 99(3):15 WEINSTOCK MB MORLEYT F See Cabreros LJ SHERBIN VL See Weinstock FJ See Curreri JP RANDRUP E See Gharib AM WILLIAMSDN Prostate-specific antigen test- SILVERSTEIN PM Urinary tract infection: Emerg- NANTEL ing for prostate cancer: Prac- Moderate Parkinson’s disease: See Berry BR - interpretation of values. 99(2): sent, Botiyf-o5r2 maximizing treat- NELSON J See O’Keefe JH Jr RAPPAPORT DC SODHI A NGHIEM HV See Dholakia S Ebola virus disease:R nizing See Stern EJ RICHARDSON JK the face of a rare killer. 99(5):75 effectivenesisn NISHIMOTO JY Peripheral neuropathy: An often- SPODICK DH t—he care clinic. 99(4): 161. Iritis: How to recognize and man- overlooked cause of falls in the Normal sinus heart rates: 60 age a potentially sight-threatening elderly. 99(6):161 and 100 BPM are too high. (CV) SSeeee Chaudhry I disease. 99(2):255 ROBERTSV L 99(2):263 Introduction to symposium on STEPHENS MB YIM PS O’BRIEN ME diabetes. 99(3):104 Gas gangrene: Potential for incontinence: Basic types Relief of suffering: Where the art See also Davidson JA baric oxygen therapy. 99(4):217 and their management in older and science of medicine meet. ROBERTSON RP STERN EJ patients. 99(5):137 99(6):189 See Gonzalez-Campoy JM Diagnostic imaging: Its role in O'KEEFE JH Jr ROCKWOOD « evaluating chest, abdominal, and ZERBE KJ Lifestyle change for coronary See MacKnight C musculoskeletal infections. 99(3): Anorexia nervosa and bulimia artery disease: What to tell pa- RODRIGUESJ C nervosa: When the pursuit of bod- tients. 99(2):89 See Cassiere H See also Gharib AM ily ‘perfection’ becomes a killer. ORTEGA AM ROHRMANNC A STIMMLERMM 99(1):161 See Cunha BA See GharibA M Infectious arthritis: Tailoring ini- Anorexia. (PN) 99(6):278 ROLNICK SJ tial treatment to clinical findings. PAIST SS il! See La Valleur J 99(4):127 Brain failure in older patients: RUOFF GE STITT JT Uncovering treatable causes of a Recurrent streptococcal pha- See Lee-Chiong TL diminished ability to think. 99(5): ryngitis: Using practical treat- STRAUSBAUGH LJ 125 ment options to interrupt the cy- See Hagman HM Functional assessment in older > 99(2):211; (correction) 99(5): patients: Key to improving qual- 4 TAN JS ity of life. 99(5):101 See File TM Jr Introduction to symposium on SANSONEL A TOWNSEND HE issues. 99(5):99 See SansoneR A See Leonard JC PETERSONA S SANSONE RA TRACHTENBARG DE See Yim PS Dysthymic disorder: The de- Getting the lead out: When is PLOUFFE JF pression that never quits. 99(6): treatment necessary? 99(3):201 See File TM Jr 233 TRONCALE JA aneJ F SETNESS PA The aging process: Physiologic ou ready to open your E- Acute bronchitis. (PN) 99(1):214 changes and pharmacologic im- maith (DD) 99(3):51 Cataracts. (PN) 99(4):282 plications. 99(5):111 Bringing your office into the The cost of caring: Who heals computer age: Do you really the healer? (ED) 99(1):15 VARON J need ail the bells and whistles? Do we really have a doctor Hypertensive crises: The need (DD) 99(5):29 glut? Or is it a question of guidin for urgent management. 99(1):189 Bumps on the entrance ramp to students to where they’re needed? the information highway. (DD) (ED) 99(5):15 WEINSTOCKF J 99(6):31 penny stress testing. (PN) Common eye disorders: Six pa- CD-ROM drives aren’t just for 99(2):2 tients to refer. 99(4):107 games anymore. (DD) 99(2):35 VOL 99/NO 6/JUNE 1996/POSTGRADUATE MEDICINE